Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effect of RA233 on platelet function in vitro.

A A Hassanein, A G Turpie, G P McNicol

    British Medical Journal
    |April 11, 1970
    PubMed
    Summary

    RA233, a novel pyrimido-pyrimidine compound, effectively inhibits platelet aggregation and function in vitro. This potent inhibitor shows greater efficacy than its analogue RA433 in various platelet inhibition assays.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Novel Human Acute Ischemic Stroke Blood Clot Analogs for In Vitro Thrombectomy Testing.

    AJNR. American journal of neuroradiology·2021
    Same author

    The Relationship Between Cerebral Reperfusion And Regional Expression Of Matrix Metalloproteinase-9 In Rat Brain Following Focal Cerebral Ischemia.

    Neuroscience·2020
    Same author

    Prevention and Treatment of Thrombosis.

    Journal of the Royal College of Physicians of London·2019
    Same author

    Animal Models of Focal Cerebral Ischaemia and Haemorrhagic Transformation: Considerations in Experimental Stroke Study Design.

    Current vascular pharmacology·2017
    Same author

    Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study.

    Journal of thrombosis and haemostasis : JTH·2015
    Same author

    Low-molecular-weight heparin: from the bench to the orthopedic patient.

    Orthopedics·2014

    Area of Science:

    • Pharmacology
    • Hematology
    • Biochemistry

    Background:

    • Platelet aggregation plays a crucial role in thrombosis and hemostasis.
    • Understanding novel inhibitors of platelet function is vital for developing antithrombotic therapies.

    Purpose of the Study:

    • To evaluate the in vitro efficacy of RA233, a new pyrimido-pyrimidine compound, as a platelet function inhibitor.
    • To compare the potency of RA233 with its analogue RA433.

    Main Methods:

    • In vitro testing of platelet aggregation inhibition induced by calcium and adenosine diphosphate (A.D.P.).
    • Assays measuring platelet retention by glass beads.
    • Evaluation of platelet factor 3 release by kaolin.
    • Assessment of clot retraction inhibition.

    Main Results:

    • RA233 demonstrated potent inhibition of calcium- and A.D.P.-induced platelet aggregation.
    • The compound effectively inhibited platelet retention and decreased platelet factor 3 release.
    • RA233 also inhibited clot retraction.
    • In specific in vitro systems, RA233 exhibited significantly greater potency than RA433.

    Conclusions:

    • RA233 is a powerful inhibitor of multiple platelet functions in vitro.
    • Its potent antiplatelet activity suggests potential therapeutic applications in conditions involving platelet hyperreactivity.

    Related Experiment Videos